B10.A mice were immunized with 1 mg/ml OVA in complete Freund’s
adjuvant (Difco,). After 7 days, popliteal lymph nodes were collected,
and T cells were isolated using a mouse CD3 enrichment column (R&D
Systems, Minneapolis, MN). T cells were cultured with irradiated
(2000R) spleen cells (5 × 106 cells/well)
from syngeneic B10.A mice in the presence of OVA (300 μg/ml) for 7
days. The T cells were seeded at 2 × 106 cells/well in a 24-well plate (Corning, Corning, NY) in Dulbecco’s
minimum essential medium (BioWhittaker, Walkerville, MD) supplemented
with 10% fetal bovine serum (Hyclone Laboratories, Logan, UT), 0.05 mM
2-mercaptoethanol (Gibco, Grand Island, NY), 25 mM HEPES
(BioWhittaker), 50 μg/ml gentamicin (Sigma), 5 μg/ml l-asparagine (Gibco), and 5 μg/ml l-arginine
(Gibco). The T cells were collected and restimulated with OVA and
syngeneic irradiated spleen cells in culture media containing 80 U/ml
mouse recombinant interleukin (IL)-2 (R&D Systems) and 4000 U/ml mouse
recombinant IFN-γ (R&D Systems). The T cells were restimulated with
OVA once every 2 to 3 weeks in the presence of syngeneic spleen cells.
Cultures of developing T cells were determined to be inflammatory Th1
cells when the T cells produced only IFN-γ with no detectable IL-4
production when stimulated by OVA antigen-presenting cells (APCs) in
the absence of exogenous growth factors (IL-2, IFN-γ) and mediated
inflammation in a standard assay of adoptive transfer of DTH.